Hamamatsu Photonics K.k. · TSE:6965
Hamamatsu Photonics K.k — FY2021 Earnings Presentation
35 slides from Hamamatsu Photonics K.k's earnings presentation, Nov 15, 2021
Slide 1: Fiscal Year ended September 30, 2021 Financial Report
Hamamatsu Photonics K.K. Fiscal Year ended September 30, 2021 Financial Report Tokyo Stock Exchange : 6965 11.15. 2021 🄫 Hamamatsu Photonics K.K. and its affiliates. All Rights Reserved. 1
Slide 2: Notes
Notes This material is not intended to be a solicitation to buy or sell any securities of Hamamatsu Photonics K.K. The information contained in this material is based on data available as of making it. No guarantees, promises are made as to its accuracy or completeness. This material includes
Slide 3: Summary of consolidated results; medium to short-term plan
1. Summary of consolidated results 2. Consolidated medium to short-term plan 🄫 Hamamatsu Photonics K.K. and its affiliates. All Rights Reserved. 3
Slide 4: Summary of consolidated financial results
Summary of consolidated financial results Performance of FY2021 • Net sales, operating profit and net profit all hit record highs. • Operating profit margin is 20.3%, the first time 20% level since FY2011. Business environment • Rapid economic recovery from COVID-19 pandemic, especially in the m
Slide 5: Consolidated financial results
Consolidated financial results Unit :Million Yen Compared FY2020 FY2021 with prev. year Sales: 1st half 79.3 billion yen (+6.3billion yen Amount Ratio from last year) 2nd half 89.6 billion yen (+22.4 billion Net Sales 140,251 169,026 28,775 20.5% yen from last year) Gross Profit 68,477 83,395 In add
Slide 6: Analysis of impact by currency fluctuation to operating profit
Analysis of impact by currency fluctuation to operating profit 2020-2021 Unit :Million Yen *Excluding currency exchange effects 40,000 Amount due to Increase of SG & A Impact by Increase of and R & D change in gross currency gross profit by expenses profit ratio fluctuation 35,000 sales increase 0 ▲
Slide 7: FY2021 sales by application
FY2021 sales by application Optical / photographic instrument Consumer instrument Others / not classified 1.1% 0.9% 4.9% Information / communication Radiographic testing instrument 26.9% 0.8% Transport instrument 2.9% Others Measuring 19.8% instrument 4.2% Analytical Medical instrument instrument Ac
Slide 8: Sales by application
Sales by application Unit :Million Yen Amount change Application FY2020 FY2021 Summary / percent change Medical-bio 11,635 • Continued demand for PCR testing and X-ray instrument 57,350 68,985 CT to deal with COVID-19 pandemic. (20.3%) • Semiconductor and FA markets are booming. Industrial 10,643 •
Slide 9: Consolidated financial results by business segment
Consolidated financial results by business segment Unit :Million Yen Amount change / Segment Account item FY2020 FY2021 percent change Summary Increase for industrial equipment. 11,396 ...In addition to the booming semiconductor market, Net sales 54,636 66,032 non-destructive testing market for lith
Slide 10: Sales by region
Sales by region Europe Europe Asia and Asia China and China Japan North America North America FY2020 2018年 22.2% 26.0% 25.9% 25.7% 9月期 FY2021 2019年 9月期 22.9% 27.4% 26.2% 23.4% Unit :Million Yen Europe Asia (of which China) Japan North America FY2020 31,160 36,432 (23,102) 36,326 36,104 FY2021 38,716
Slide 11: Capital investment, Depreciation, R & D expense
Capital investment, Depreciation, R & D expense Unit :Million Yen Capital investment Depreciation R & D expense and 25000 25000 14000 ratio of R & D expenses to 9.0% sales 20,337 13000 8.7% 8.0% 20000 20000 12000 6.7% 7.0% 11000 6.0% 15000 12,982 15000 12,147 12,402 10000 5.0% 11,758 11,367 9000 4.0
Slide 12: Summary of consolidated results; medium to short-term plan
1. Summary of consolidated results 2. Consolidated medium to short-term plan 🄫 Hamamatsu Photonics K.K. and its affiliates. All Rights Reserved. 12
Slide 13: Summary of FY2022 and medium to short-term plan
Summary of FY2022 and medium to short-term plan Summary of FY2022 • Net sales, operating profit, and net profit all hit record highs. Medium to short-term plan • Three-year CAGR rate of 6.3%. • Continuously maintain operating margin of more than 20%. • Capital investment exceeds 20 billion yen e
Slide 14: Sales & profit through FY2024
Sales & profit through FY2024 Sales Unit :Million Yen Profit 50,000 200,000 Sales are expected 45,000 to increase mainly in 180,000 40,000 industrial instrument. 35,000 160,000 High growth rates 30,000 are expected for 140,000 25,000 academic research 20,000 where large projects 120,000 are expe
Slide 15: Consolidated financial forecast
Consolidated financial forecast Unit :Million Yen Compared Sales: 1st half 93.7billion yen (+14.3billion yen FY2021 FY2022 with prev. year (Result) (Plan) from last year) Amount Ratio 2nd half 89.1billion yen (−0.5billion yen Net Sales 169,026 182,800 13,774 8.1% from last year) Gross Profit 83,395
Slide 16: Analysis of impact by currency fluctuation to operating profit (trial calculation)
Analysis of impact by currency fluctuation to operating profit (trial calculation) 2021-2022 *Excluding currency exchange effects Unit :Million Yen 50,000 Amount due to Increase of change in gross Increase of SG & A Impact by gross profit by profit ratio and R & D expenses currency 45,000 sales incr
Slide 17: Consolidated sales forecast by application
Consolidated sales forecast by application Unit :Million Yen FY2021 FY2022 Amount of change Application Summary (Result) (Plan) / percent change • Special demand to deal with COVID-19 pandemic to Medical-bio 2,536 instrument 68,985 71,521 decrease, but demand for dental application to (3.7%) recover
Slide 18: Consolidated sales forecast by business segment
Consolidated sales forecast by business segment Unit :Million Yen FY2021 FY2022 Amount change / Segment Account item percent change Summary (Result) (Plan) 2,768 Increase for Industrial Equipment... Net sales 66,032 68,800 Continuing growth in demand for lithium-ion battery (4.2%) testing. Electron
Slide 19: Plans of Capital investment, Depreciation, R & D expense
Plans of Capital investment, Depreciation, R & D expense Unit :Million Yen Capital investment, Depreciation R & D expense and 30,000 ratio to sales New buildings …10,900 30,000 10.0% 25,000 9.0% New buildings 28,700 25,000 …10,100 7.4% 8.0% 6.7% 7.1% 6.8% New buildings 24,300 7.0% 20,000 20,000 …13,
Slide 20: Group companies and offices worldwide
Asia Americas HAMAMATSU PHOTONICS K.K. HAMAMATSU CORPORATION Headquarters Main Office / California Office HAMAMATSU PHOTONICS (CHINA)Co., Ltd. PHOTONICS MANAGEMENT Corp. Main Office / Shanghai Branch / Shenzhen Branch ENERGETIQ TECHNOLOGY, Inc. BEIJING HAMAMATSU PHOTON TECHNIQUES INC. Main Office /
Slide 21: 🄫 Hamamatsu Photonics K.K. and its affiliates. All Rights Reserved.
🄫 Hamamatsu Photonics K.K. and its affiliates. All Rights Reserved. 21
Slide 22: Fiscal Year ended September 30, 2021 Databook
Hamamatsu Photonics K.K. Fiscal Year ended September 30, 2021 Databook Tokyo Stock Exchange : 6965 11.15.2021 🄫 Hamamatsu Photonics K.K. and its affiliates. All Rights Reserved. 22
Slide 23: Notes
Notes This material is not intended to be a solicitation to buy or sell any securities of Hamamatsu Photonics K.K. The information contained in this material is based on data available as of making it. No guarantees, promises are made as to its accuracy or completeness. This material includes
Slide 24: Consolidated income statements
Consolidated income statements Unit :Million Yen FY2020 FY2021 FY2022(Plan) FY2023(Plan) FY2024(Plan) 1st half 2nd half Year % 1st half 2nd half Year % 1st half 2nd half Year % Year % Year % Net sales 72,975 67,276 140,251 100.0 79,342 89,684 169,026 100.0 93,700 89,100 182,800 100.0 188,800 100.0 2
Slide 25: Consolidated sales by application
Consolidated sales by application Unit :Million Yen FY2020 FY2021 FY2022 (Plan) Application st nd st nd st 1 half 2 half Year % 1 half 2 half Year % 1 half 2nd half Year % Radiographic testing 22,366 17,800 40,166 28.6 21,523 23,917 45,441 26.9 24,901 23,142 48,043 26.3 Medical-bio Laboratory testin
Slide 26: Sales by application of Electron tube segment
Sales by application of Electron tube segment Unit :Million Yen FY2020 FY2021 FY2022 (Plan) Application st nd st nd st 1 half 2 half Year % 1 half 2 half Year % 1 half 2nd half Year % Radiographic testing 5,874 4,482 10,356 19.0 4,794 5,355 10,150 15.4 4,992 4,389 9,382 13.6 Medical-bio Laboratory t
Slide 27: Sales by application of Opto-semiconductor segment
Sales by application of Opto-semiconductor segment Unit :Million Yen FY2020 FY2021 FY2022 (Plan) Application st nd st nd st 1 half 2 half Year % 1 half 2 half Year % 1 half 2nd half Year % Radiographic testing 16,481 13,317 29,798 44.7 16,726 18,557 35,284 45.0 19,907 18,751 38,658 44.9 Medical-bio
Slide 28: Sales by application of Imaging and measurement instruments segment
Sales by application of Imaging and measurement instruments segment Unit :Million Yen FY2020 FY2021 FY2022 (Plan) Application st nd st nd st 1 half 2 half Year % 1 half 2 half Year % 1 half 2nd half Year % Radiographic testing 7 0 7 0.0 0 2 2 0.0 0 0 0 0.0 Medical-bio Laboratory testing 1,147 1,873
Slide 29: Major subsidiaries income statements
Major subsidiaries income statements Local currency (thousand local currency) Yen (million yen) Company Account item FY2020 FY2021 FY2020 FY2021 Year % Year % Year Year Net sales 377,686 100.0 442,175 100.0 40,737 47,551 Hamamatsu Corporation Gross profit 74,460 19.7 80,273 18.2 8,031 8,632 sales co
Slide 30: 2020-2024 consolidated forecast by business segment
2020-2024 consolidated forecast by business segment Unit :Million Yen FY2022 FY2020 FY2021 FY2023 FY2024 (Plan) (Plan) (Plan) 1st half 2nd half Year 1st half 2nd half Year 1st half 2nd half Year Electron tube 28,626 26,010 54,636 30,448 35,584 66,032 35,300 33,500 68,800 70,800 74,650 Opto- 35,219 3
Slide 31: 2020-2024 Electron tube's consolidated forecast
2020-2024 Electron tube's consolidated forecast Unit :Million Yen FY2022 FY2023 FY2024 FY2020 FY2021 (Plan) (Plan) (Plan) 1st half 2nd half Year % 1st half 2nd half Year % 1st half 2nd half Year % Year % Year % Net sales 28,626 26,010 54,636 100.0 30,448 35,584 66,032 100.0 35,300 33,500 68,800 100.
Slide 32: 2020-2024 Opto-semiconductor's consolidated forecast
2020-2024 Opto-semiconductor's consolidated forecast Unit :Million Yen FY2022 FY2023 FY2024 FY2020 FY2021 (Plan) (Plan) (Plan) 1st half 2nd half Year % 1st half 2nd half Year % 1st half 2nd half Year % Year % Year % Net sales 35,219 31,447 66,666 100.0 36,764 41,654 78,418 100.0 43,400 42,650 86,050
Slide 33: 2020-2024 Imaging & measurement instrument's consolidated forecast
2020-2024 Imaging & measurement instrument's consolidated forecast Unit :Million Yen FY2022 FY2023 FY2024 FY2020 FY2021 (Plan) (Plan) (Plan) 1st half 2nd half Year % 1st half 2nd half Year % 1st half 2nd half Year % Year % Year % Net sales 8,110 8,644 16,754 100.0 10,432 11,111 21,543 100.0 12,950 1
Slide 34: Consolidated capital investment, R & D expenses and depreciation
Consolidated capital investment, R & D expenses and depreciation Unit :Million Yen FY2016 FY2017 FY2018 FY2019 FY2020 FY2021 Ratio to Ratio to Ratio to Ratio to Ratio to Ratio to Amount Amount Amount Amount Amount Amount sales (%) sales (%) sales (%) sales (%) sales (%) sales (%) 1st quarter 1,441 4
Slide 35: 🄫 Hamamatsu Photonics K.K. and its affiliates. All Rights Reserved.
🄫 Hamamatsu Photonics K.K. and its affiliates. All Rights Reserved. 35
Hamamatsu Photonics K.K. — FY2021 Earnings Presentation on 6ix